How to Buy Black Diamond Therapeutics Stock
Black Diamond Therapeutics Inc
Black Diamond Therapeutics, Inc. is a biotechnology enterprise dedicated to discovering, advancing, and bringing to market therapeutic agents specifically designed for patients with genetically characterized tumors.
Black Diamond Therapeutics stock last closed at $1.75, down 3.85% from the previous day, and has decreased 27.98% in one year. It has overperformed other stocks in the Biotechnology industry by 0.45 percentage points. Black Diamond Therapeutics stock is currently +0.29% from its 52-week low of $1.75, and -64.57% from its 52-week high of $4.94.
As of Jun 12, 2026, there are 57.3M shares of BDTX outstanding. The market capitalization of BDTX is $100.28M. In the last 24 hours, 2.31M BDTX shares were traded.
How to Buy Black Diamond Therapeutics Stock
Not sure how to invest in Black Diamond Therapeutics stock? Here's how.
- Decide where to buy Black Diamond Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you figure out where to buy Black Diamond Therapeutics stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit money your investment account: Choose your method of payment and add your information.
- Analyze Black Diamond Therapeutics stock: The Black Diamond Therapeutics ticker symbol is BDTX. Is Black Diamond Therapeutics stock a good investment? Should you buy shares of BDTX? How do BDTX's underlying business fundamentals look? Do top analysts think Black Diamond Therapeutics is a good buy? Why has BDTX's stock price moved recently? (Hint: Our stock research website can help you evaluate if BDTX is a good stock to buy).
- Make your BDTX trade: Decide if you will purchase BDTX shares at the current market price or use a limit order to purchase BDTX shares at a given price.
- Get updates on your investment in BDTX: Create a watchlist to keep tabs on your position in Black Diamond Therapeutics shares.
Step 1: Decide where to buy Black Diamond Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy BDTX shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Utilities, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've selected the best brokerage, you'll need to fill out some personal details so you are able to buy BDTX today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to open a new brokerage account.
- Send your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have finished signing up on investing apps, you can securely and quickly fund your account:
Check out this video walkthrough to see the process of transferring money into your investment account.
Step 4: Analyze Black Diamond Therapeutics stock
Once you have selected the best place to buy Black Diamond Therapeutics stock, it's absolutely critical to analyze their stock before you buy, so you truly wrap your head around the risk and opportunity.
Black Diamond Therapeutics quick stats
BDTX Due Diligence Checks
WallStreetZen was built to help average investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on BDTX's stock page.
How is BDTX stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge BDTX's fair value.
Using relative valuations ratios:
- BDTX could be undervalued based on its P/B ratio of 0.96x, relative to Biotechnology industry P/B ratio of 4.85x
You can access more valuation research on BDTX's stock here.
BDTX Financial Health Overview
Signs that BDTX is financially healthy:
- BDTX has a low debt to equity ratio of 0.27.
- There are more short-term assets than long-term liabilities on the BDTX balance sheet.
- There are more short-term assets than short-term liabilities on the BDTX balance sheet.
- BDTX has $119.09M in cash and short term investments. This is enough to cover its annual cash burn of $34.01M.
- BDTX has cash burn of 34014000. It has sufficient cash and short-term investments to cover this for at least one year.
Signs that BDTX is not financially healthy:
- Total BDTX debt is higher than 5 years ago, relative to shareholder equity.
Is it a good time to buy BDTX stock, according to Wall Street analysts?
Out of 3 Wall Street analysts who give recommendations on BDTX, the consensus analyst rating on Black Diamond Therapeutics is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Black Diamond Therapeutics stock forecast page.
BDTX Technicals
BDTX Growth Numbers
Last year, BDTX revenue was $0.00. During the last 1 years, BDTX's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 32.07%.
Find out more about BDTX's earnings and revenue performance here.
Are BDTX executives and large shareholders buying or selling the stock?
In the past 12 months, insiders at BDTX have bought more shares than they have sold.
Ali Behbahani, Director of BDTX, was the latest BDTX insider to buy. They bought $14,875.85 worth of BDTX stock on Mar 20, 2026.
Get more info about who owns BDTX stock here.
Does BDTX stock generate passive income?
No, Black Diamond Therapeutics doesn't provide an income stream by paying out dividends.
BDTX Social Trading Data
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Make your BDTX trade
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are generally fine for most investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific price limit, place a limit order.
Click the Open Trade button and your broker will execute your order.
If you need more assistance buying stocks on eToro, click the how to video below:
Step 6: Get updates on your investment in BDTX
Now that you own some BDTX shares, you'll want to stay up-to-date on your new company.
Make a watchlist to monitor your BDTX stock.
BDTX Feed
How to Buy Stock in Black Diamond Therapeutics
To summarize, here are the 6 steps to buy stock in Black Diamond Therapeutics:
- Decide where to buy Black Diamond Therapeutics stock
- Create a brokerage account
- Deposit money your investment account
- Analyze Black Diamond Therapeutics stock
- Make your BDTX trade
- Get updates on your investment in BDTX
If you require a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you want to watch your new investment in Black Diamond Therapeutics, create a watchlist today.
More Content You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.